- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04683042
Fibromyalgia TENS in Physical Therapy Study (TIPS): an Embedded Pragmatic Clinical Trial
The purpose of this study is to determine if addition of Transcutaneous Electrical Nerve Stimulation (TENS) to routine physical therapy improves movement-evoked pain in patients with fibromyalgia (FM).
The study will also determine if addition of TENS to routine physical therapy (PT) improves disease activity and symptoms, increases adherence to physical therapy, increases the likelihood of meeting patient specific functional goals, and reduces medication use.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a pragmatic clinical trial in outpatient PT practices utilizing cluster randomization by healthcare system and facility size. Sites will be randomized to enroll all eligible and consented participants with FM to TENS with PT, or PT only (no TENS). We are identifying 25-35 clinics across 6 healthcare systems in both rural and urban settings. We will enroll 450 patients that self report a clinician diagnosis of FM. At each site, TENS (or no TENS) will be applied during each visit along with individualized PT treatment specified by the physical therapist. Participants randomized to TENS intervention sites will receive TENS units and electrodes at baseline to be applied to the cervical and lumbar regions. Participants will take the units home and bring the units back to their PT clinic visits with instructions for use at home while active and during their exercises. The physical therapist at each clinic will complete routine documentation of treatment. In addition to the primary and secondary outcomes, Electronic Health Record data variables will be collected as exploratory outcomes. Variables including adherence to treatment will be extracted from each site's Electronic Health Record. Patient-reported assessments will be obtained from the participant's at home the day of their second PT visit (Baseline) and at 30, 60 (primary outcome), 90, and 180 days following enrollment. The primary and secondary outcome assessments will be comparing TENS and no TENS groups in terms of changes from baseline to 60 days.
Participants will be identified after they are referred for PT for treatment of primary fibromyalgia (FM) or chronic pain (pain lasting more than three months). At their first (intake) physical therapy visit, they will be provided information about the study that can be accessed on paper or on-line. They will perform an electronic screening form on the first visit if interested in participating. Participants will provide e-consent after eligibility is confirmed at the initial PT visit. At the second PT visit after e-consent is signed, participants will be provided instructions on logging onto REDCap for data capture and accessing the case report forms. Participants enrolled at a TENS site will then be instructed in use of TENS and the TENS unit with electrodes will be provided. Those participants enrolled at a no TENS site will skip the instruction in use of TENS but will then receive instructions along with the TENS units at day 65. Participants will be instructed to capture all baseline assessments at home before their next PT visit before and following their first TENS treatment (or no TENS) at home (day 1). At 30, 60, 90, and 180 days following enrollment, participants will complete the same assessments at home including pain ratings at rest and with movement along with questionnaires. The primary and secondary outcome assessments will be comparing TENS and no TENS groups in terms of changes from baseline to 60 days.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Michele Costigan, RN
- Phone Number: 319.467.4203
- Email: fmtips-studyteam@uiowa.edu
Study Contact Backup
- Name: Elizabeth Johnson, PhD
- Phone Number: 319.467.4203
- Email: fmtips-studyteam@uiowa.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60607
- Recruiting
- University of Illinois at Chicago
-
Moline, Illinois, United States, 61265
- Recruiting
- Rock Valley Physical Therapy
-
-
Iowa
-
Cedar Rapids, Iowa, United States, 52404
- Recruiting
- Kepros Physical Therapy and Performance
-
Davenport, Iowa, United States, 52807
- Active, not recruiting
- Genesis Physical Therapy
-
-
South Dakota
-
Big Stone City, South Dakota, United States, 57216
- Recruiting
- Big Stone Therapies (BST)
-
-
Wisconsin
-
Appleton, Wisconsin, United States, 54913
- Recruiting
- Advanced Physical Therapy Sport Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 until 99.
- Clinician diagnosis of FM
- Referred for land-based PT
- Referred for treatment for FM or chronic pain (pain lasting more than 3 months)
- Able to provide informed consent.
- Fluent in reading English
- Willing to use TENS
Exclusion Criteria:
Contraindications to TENS use including:
- Pacemaker, defibrillator, implanted neurostimulator or implanted device
- Epilepsy
- Currently pregnant or plan to become pregnant in the next 6 months
- Allergic reaction to patches with gel
- Current treatment for cancer
- Currently enrolled in another pain control study
- Use of TENS within the last 30 days
- Clinically unstable medical or psychiatric issues
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: TENS with PT
TENS with PT group: The TENS with PT group will receive usual PT care and following enrollment, during the second PT visit, participants will receive TENS units and instruction on use of the TENS units.
TENS will be applied to the upper and lower back with butterfly electrodes using the following parameters: mixed frequency (2-125Hz), strong but comfortable intensity, variable pulse duration from 100-250 microseconds.
TENS to be applied when the patient is active and doing exercises at home and during PT sessions for 30 minutes at least 2 hours per day.
The TENS with PT group will complete TENS use to the end of the study at 6 months.
|
Use of TENS units along with routine PT therapy
|
Other: No TENS with PT
The No TENS group will receive usual PT care until the primary endpoint timeframe of 60 days.
After completion of the research homework at 60 days, TENS units will be mailed to the participants and a study team member will complete virtual TENS instruction.
The no TENS group will complete TENS to the end of the study at 6 months.
|
Routine PT therapy only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of movement-evoked pain (0-10 Low to High scale) during the Sit and Stand Test
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Numeric rating scale of 0-10 for reduction of movement-evoked pain measured by 11-point NRS from baseline to 60 days.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the resting pain score (0 - 10 Low to High scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
The severity of pain will be measured on a 0 to 10 numeric rating scale where 0 is no-pain and 10 is worst pain imaginable.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Pain interference (BPI) (0-10 Low to High Scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
11 items measuring pain severity and interference with daily activities on a 0-10 scale.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
FM Disease activity (FIQR) (0-10 Low to High Scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
21 items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Resting fatigue (NRS) (0-10 Low to High Scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
The severity of fatigue will be measured with a 0 to 10 scale where 0 is no fatigue and 10 is worst fatigue imaginable.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Movement-evoked fatigue (NRS) (0-10 Low to High Scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Fatigue during a five times sit and stand test will be measured with a 0 to 10 numeric rating scale with 0 as no fatigue and 10 as the worst fatigue imaginable.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Multidimensional assessment of fatigue (MAF) (0-10 Low to High Scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
16 items measuring fatigue according to four dimensions: degree and severity, distress that it causes, timing of fatigue, and impact on various activities of daily living.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Rapid assessment of physical activity (RAPA) (0-10 Low to High Scale)
Time Frame: Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
9 items evaluating current level of physical activity.
|
Research Homework before PT Visit 3 (Day 1), Day 60 +/- 5 days Home
|
Patient global impression of change (PGIC) (0-6 Scale)
Time Frame: Day 60 +/- 5 days Home
|
Evaluates overall health status as perceived by the patient in a seven-point single-item scale ranging from 'very much worse' to 'very much improved'
|
Day 60 +/- 5 days Home
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathleen Sluka, PhD, PT, University of Iowa
- Principal Investigator: Leslie Crofford, MD, Vanderbilt University
- Study Director: Dana Dailey, PhD, PT, University of Iowa
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201909757
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
In accordance with NIH Collaboratory policies, we will prepare the primary analysis datasets (at a minimum) for submission to the Collaboratory Coordinating Center. In accordance with International Committee of Medical Journal Editors (ICMJE) policies, we will prepare the primary analysis datasets for review and reproducibility by peer-reviewed journals. We will prepare the final datasets and accompanying resource documents for final deposit to the designated NIH HEAL data repository.
Publications will be made available to the public using open access publishing, so they become available immediately to the public. All publications will be accessible through PubMED, google scholar, and available to the public through open access.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
-
Yousra Hisham Abdel FattahCompletedFibromyalgia, PrimaryEgypt
-
Forest LaboratoriesCypress Bioscience, Inc.TerminatedPrimary FibromyalgiaUnited States
-
Universidade Federal do Rio Grande do NorteCompleted
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
University of ManitobaCompleted
Clinical Trials on Transcutaneous Electrical Nerve Stimulation (TENS) with PT
-
University Hospital, ToulouseMinistry of Health, FranceTerminatedPeripheral Artery DiseaseFrance
-
Karolinska University HospitalActive, not recruitingHip Fractures | Hip Osteoarthritis | Orthopedic Disorder | Post Operative PainSweden
-
Institut Cancerologie de l'OuestTerminated
-
Tufts Medical CenterNot yet recruitingAnalgesia | Pain, Acute | Patient Preference | IUDUnited States
-
Fatih Sultan Mehmet Training and Research HospitalCompleted
-
Hawaii Pacific HealthUnknownAnalgesia | Cesarean Section | Transcutaneous Electric Nerve StimulationUnited States
-
European University of LefkeCompletedLateral Epicondylitis (Tennis Elbow) Bilateral | Pain in Arm, Unspecified | Tenosynovitis Elbow
-
Hospital of South West JutlandTerminated
-
University of Campinas, BrazilCompletedEndometriosisBrazil
-
Mayo ClinicElira Therapeutics, Inc.TerminatedObesityUnited States